about
Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiaeExtrachromosomal psi+ determinant suppresses nonsense mutations in yeastThe ubiquitin-conjugating enzyme Rad6 (Ubc2) is required for silencing in Saccharomyces cerevisiae.Alterations in ribosomal protein RPS28 can diversely affect translational accuracy in Saccharomyces cerevisiae.An accuracy center in the ribosome conserved over 2 billion years.Prions affect the appearance of other prions: the story of [PIN(+)].The translational function of nucleotide C1054 in the small subunit rRNA is conserved throughout evolution: genetic evidence in yeastRole of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]Heterologous cross-seeding mimics cross-species prion conversion in a yeast model.The relationship between visible intracellular aggregates that appear after overexpression of Sup35 and the yeast prion-like elements [PSI(+)] and [PIN(+)].Modulation of Abeta42 low-n oligomerization using a novel yeast reporter systemYeast Ty1 retrotransposition is stimulated by a synergistic interaction between mutations in chromatin assembly factor I and histone regulatory proteins.Analyzing the birth and propagation of two distinct prions, [PSI+] and [Het-s](y), in yeast.The yeast non-Mendelian factor [ETA+] is a variant of [PSI+], a prion-like form of release factor eRF3.Prion formation and polyglutamine aggregation are controlled by two classes of genes.Analysis of yeast retrotransposon Ty insertions at the CAN1 locus.Isolation of omnipotent suppressors in an [eta+] yeast strain.The yeast omnipotent suppressor SUP46 encodes a ribosomal protein which is a functional and structural homolog of the Escherichia coli S4 ram protein.The yeast translational allosuppressor, SAL6: a new member of the PP1-like phosphatase family with a long serine-rich N-terminal extension.Development and validation of a yeast high-throughput screen for inhibitors of Aβ₄₂ oligomerization.A deletion map of cyc1 mutants and its correspondence to mutationally altered iso-1-cytochromes c of yeast.Inhibition of growth by amber suppressors in yeast.Isolation and characterization of amber suppressors in yeast.Allosuppressors that enhance the efficiency of omnipotent suppressors in Saccharomyces cerevisiae.Progress toward an ultimate proof of the prion hypothesis.Protein folding: sticky N17 speeds huntingtin pile-up.Prion-promoted phosphorylation of heterologous amyloid is coupled with ubiquitin-proteasome system inhibition and toxicity.Isolation and properties of an antisuppressor in Saccharomyces cerevisiae specific for an omnipotent suppressorChimeric rRNAs containing the GTPase centers of the developmentally regulated ribosomal rRNAs of Plasmodium falciparum are functionally distinctMutations in helix 27 of the yeast Saccharomyces cerevisiae 18S rRNA affect the function of the decoding center of the ribosome.Retrospective. Fred Sherman (1932-2013).Interactions among prions and prion "strains" in yeast.Heterologous gln/asn-rich proteins impede the propagation of yeast prions by altering chaperone availabilityAnalysis of amyloid aggregates using agarose gel electrophoresis.Host genes that affect the target-site distribution of the yeast retrotransposon Ty1Destabilizing interactions among [PSI(+)] and [PIN(+)] yeast prion variants.Dependence and independence of [PSI(+)] and [PIN(+)]: a two-prion system in yeast?Heterologous aggregates promote de novo prion appearance via more than one mechanism.Overexpression of the SUP45 gene encoding a Sup35p-binding protein inhibits the induction of the de novo appearance of the [PSI+] prion.A non-Q/N-rich prion domain of a foreign prion, [Het-s], can propagate as a prion in yeast.
P50
Q24533260-152892c0-4320-6d56-749d-eb2153028bf4Q24684840-f9315b50-420b-dd0f-da20-4122599bcc79Q27934959-20886b6c-4952-9396-590d-67f634df6321Q27936038-69244689-45fd-0f68-a856-3a1f5f2dfbadQ27936213-c7bb3c6c-4b6f-cf94-8d3b-ad38a31926efQ27937880-63e82f79-45b0-9a23-f7a9-d80941fc1009Q28776078-b84660dc-49ce-f130-f983-c990baf59df7Q29619693-11e81d02-42bb-f1d1-c1b4-776723edc1bdQ30377551-a34d39d7-4823-b6dc-a5fd-6a4357826754Q31727422-d3aa9386-4943-85f4-d8e1-c2e57c2a377fQ33258510-8082c9e4-49b7-f0c6-2ec0-62f33d594da1Q33775888-ad2fc496-40ac-b6fc-6634-352e25aced93Q33818444-dcc5f999-4c03-24af-b762-5bf8e5a241e1Q33890487-c79d51d2-40b1-0ea0-f47c-53c67cbe9928Q33916796-d1f57d38-47ad-7595-fb08-ca58c099e7b2Q33956000-ed75131a-4fa5-ea09-c4ba-4ae4e0b6e3b1Q33956239-5b84f81e-46b4-571d-5bc1-9bb5713ea6baQ33959932-552e4c67-4280-63fd-ee4d-9d6c9e5f5883Q33963825-68f0de48-4ba7-a6b4-7214-be978858e029Q33979228-dcf8d486-4f0f-e562-ca08-b39484c7df13Q33990850-fffd4105-4631-9a20-7cdb-d6a6d35f2da3Q33991091-0cb32212-476b-3347-3e8f-26f4bf7e6680Q33991098-2cd44839-4d4f-1310-8182-9f3de573b8e5Q33998971-9f7f092c-4db1-2005-45bf-7ac156b6cc8cQ34033631-fe42d7ea-4fc7-97c9-c533-3fa4e416c4e3Q34088566-c5e72291-4862-cadb-6863-fd83d3e56501Q34115717-33a3e429-405e-a99d-cd12-4283da0cfaa2Q34155158-305a31c1-4693-ba44-6620-483dc27deea0Q34361393-4a4bb491-4c9f-a73c-bbad-ee81e78ee791Q34362931-771526f2-4998-718f-1406-4eff47295671Q34388710-b701d9c6-4b83-d437-76a3-b74d3da29279Q34443841-7b0ead7a-4e7c-8ba2-9e15-7edc6507025aQ34566018-c3d7a696-4cdd-1657-009d-2afd226f9b42Q34574554-bd790076-45e5-64e7-95f8-d25adf822710Q34606562-4d9640a5-43f1-d37b-9783-658c2223ca89Q34619382-79504643-4e94-3cbe-2142-5dd3425c8d4eQ34669467-f38f9d48-4d8b-38f4-12a8-d5e8a7fa039eQ35539781-fbfcdb5f-4349-2e72-6101-5d0a8ce08961Q35917933-bea03ae2-44b8-0898-9757-f9e4adf7ff03Q36015339-0457ad3f-4be3-fa04-4dee-5b0615b15f32
P50
description
biomedical researcher
@en
onderzoeker
@nl
name
Susan W. Liebman
@ast
Susan W. Liebman
@en
Susan W. Liebman
@es
Susan W. Liebman
@nl
type
label
Susan W. Liebman
@ast
Susan W. Liebman
@en
Susan W. Liebman
@es
Susan W. Liebman
@nl
altLabel
Susan Liebman
@en
Susan W Liebman
@en
prefLabel
Susan W. Liebman
@ast
Susan W. Liebman
@en
Susan W. Liebman
@es
Susan W. Liebman
@nl
P69
P106
P1153
7005026073
P1960
3vz3zh8AAAAJ
P2038
Susan_Liebman